MRI identifies MCI subtypes: vascular versus neurodegenerative

Area of Science:

• Gerontology
• Neurology
• Public Health

Background:

• Global life expectancy increases, leading to a rise in cognitive impairment and dementia.
• Mild cognitive impairment (MCI) represents an early, subtle cognitive decline in the elderly, often preceding dementia.
• MCI increases the risk for various dementia types, including Alzheimer's disease and vascular dementia.

Purpose of the Study:

• To highlight the public health significance of cognitive impairment and dementia in aging populations.
• To introduce a combined screening method (CMC) for diagnosing MCI.
• To discuss the progression rates of MCI to different dementia subtypes.

Main Methods:

• Utilized psychometric screening combining the Mini-Mental Status Examination (MMSE) and Cognitive Capacity Screening Examination (CCSE), termed CMC.
• Identified individuals with MCI, noting their increased risk for dementia.
• Reviewed progression rates of MCI to dementia (Alzheimer's and vascular types) based on existing literature.

Main Results:

• The combined screening (CMC) aids in confirming MCI diagnosis.
• Between 19% and 50% of MCI cases progress to dementia within 3-5 years.
• In the US, two-thirds of MCI progress to Alzheimer's dementia and one-third to vascular dementia.

Conclusions:

• MCI is a critical prodromal stage for dementia, necessitating early detection.
• The CMC screening method offers a valuable tool for identifying individuals with MCI.
• Understanding MCI progression is crucial for developing targeted interventions and managing public health challenges associated with dementia.